Close Menu
Trade Verdict
  • Home
  • Latest News
  • Investing
  • Personal Finance
  • Retirement
  • Economy
  • Stocks
  • Bonds
  • Commodities
  • Cryptocurrencies
Facebook X (Twitter) Instagram
Trade Verdict
  • Latest News
  • Investing
  • Personal Finance
  • Retirement
  • Economy
Facebook X (Twitter) Instagram
Trade Verdict
Stocks

Merck & Co., Inc. (MRK) Shareholder/Analyst Name Transcript

EditorialBy EditorialNovember 10, 2025No Comments2 Mins Read

[ad_1]

Merck & Co., Inc. (MRK) Shareholder/Analyst Name November 9, 2025 7:01 PM EST

Firm Individuals

Peter Dannenbaum – Vice President of Investor Relations
Dean Li – Government VP & President of Merck Analysis Laboratories
Joerg Koglin – Senior VP & Head of Normal Drugs – World Scientific Growth
Jannie Oosthuizen – Senior VP & President Merck U.S. Human Well being

Convention Name Individuals

Taylor Hanley – JPMorgan Chase & Co, Analysis Division
Daina Graybosch – Leerink Companions LLC, Analysis Division
Nick Jennings – Goldman Sachs Group, Inc., Analysis Division
Malcolm Hoffman – BMO Capital Markets Fairness Analysis
Vamil Divan – Guggenheim Securities, LLC, Analysis Division
Courtney Breen – Sanford C. Bernstein & Co., LLC., Analysis Division
Steve Scala – TD Cowen, Analysis Division

Presentation

Operator

Welcome to the Merck & Co., Inc., Rahway, New Jersey, U.S.A. AHA Investor Occasion. [Operator Instructions] This name is being recorded. When you’ve got any objections, it’s possible you’ll disconnect at the moment.

I might now like to show the decision over to Mr. Peter Dannenbaum from Senior Vice President, Investor Relations. Sir, it’s possible you’ll start.

Peter Dannenbaum
Vice President of Investor Relations

Thanks, Ivy. Good night, and welcome to Merck’s investor occasion coinciding with the American Coronary heart Affiliation Scientific Classes 2025. Thanks to these with us right here in New Orleans and likewise to these taking part by way of the webcast. We respect your curiosity in Merck.

Earlier than we get began, I might wish to remind you that a few of the statements that we make in the present day could also be thought-about forward-looking statements inside the that means of the protected harbor provision of the U.S. Personal Securities Litigation Reform Act of 1995. Such statements are made based mostly on the present beliefs of our firm’s administration and are topic to vital dangers and uncertainties. If our underlying assumptions show inaccurate or uncertainties materialize, precise outcomes could differ materially from these set forth within the

[ad_2]

Editorial
  • Website

Related Posts

Why some staff will not profit from the deduction

December 24, 2025

GoodRx: The Tide Is Shifting Out Of This Firm's Favor (Downgrade)

December 24, 2025

Shares making the most important strikes premarket: NKE, DVAX, PATH

December 24, 2025

The Gabelli Gold Fund, Inc. Q3 2025 Commentary

December 24, 2025
Add A Comment
Leave A Reply Cancel Reply

Trade Verdict
Facebook X (Twitter) Instagram Pinterest
  • About Us
  • Contact Us
  • Privacy Policy
  • Terms Of Service
© 2026 Trade Verdict. All rights reserved by Trade Verdict.

Type above and press Enter to search. Press Esc to cancel.